India needs to rethink IPO norms for biotech start-ups: Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw urges IPO reforms, saying India's listing norms hinder biotech firms that need long R&D cycles before generating revenue

Go to News Site